Erlocip 150mg Tablet

Erlocip 150mg Tablet

Prescription requiredRx Required

Salt Composition: Erlotinib

Expiry Date: 01/2028

Special offer

Buy at $157.20

$157.20

Inclusive of all taxes

30 tablet

About The Product

non-small cell lung cancer (NSCLC) and pancreatic cancer

Erlocip 150mg Tablet is a prescription-based anticancer medicine. It is used for the treatment of pancreatic cancer and non-small cell lung cancer. This tablet has a salt constituent called 'Erlotinib,' which belongs to the drug class of 'kinase inhibitors. It stops the activity of the abnormal protein that leads to cancerous growth. Take it exactly as prescribed at the fixed time each day for better results.

Side Effects

  • Side effects are unwanted symptoms that can occur from any medical treatment.
  • Like other medications, the Erlocip 150mg Tablet can also have adverse effects on the body, most of which resolve without the need for medical attention.
  • Some common side effects include: Abdominal pain Bone pain Breathlessness Constipation Cough Diarrhea Fatigue Fever Infection Muscle pain Nausea Rash Stomatitis (Inflammation of the mouth)
  • Vomiting Weight loss Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • The doctor determines the dosage and treatment duration with Erlocip 150mg Tablet as per the patient's health condition and stage of cancer.
  • This tablet should be taken orally without food.
  • Don't chew or crush the tablet.
  • In the case of overdose, contact your doctor immediately.

Safety Advice

Alcohol

The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking the Erlocip 150mg Tablet. It is advised to consult your doctor for further information.

Pregnancy

Erlocip 150mg Tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition.

Breast Feeding

Erlocip 150mg Tablet is probably not safe if you're breastfeeding. Kindly consult your doctor.

Driving

It is advisable not to drive or operate heavy machinery after taking an Erlocip 150mg Tablet, as you may feel dizzy.

Kidney

Erlocip 150mg Tablet is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

Liver

Inform your doctor before starting the Erlocip 150mg Tablet if you have liver disease to avoid any serious side effects.

Missed Doses

  • ​ If the patient misses a dose of medicine, skip it and continue with the normal schedule.
  • No need to double the dose ​

Reference

1. Bonomi, P.

(2003). Erlotinib: a new therapeutic approach for non-small cell lung cancer.

Expert opinion on investigational drugs, 12(8), 1395-1401. 2.

Kelley, R. K., & Ko, A.

H. (2008).

Erlotinib in the treatment of advanced pancreatic cancer. Biologics: targets and therapy, 2(1), 83-95.

3. Kelley, R.

K., & Ko, A. H.

(2008). Erlotinib in the treatment of advanced pancreatic cancer.

Biologics: targets and therapy, 2(1), 83-95. 4.

Liu, V., White, D. A., Zakowski, M.

F., Travis, W., Kris, M. G., Ginsberg, M.

S., ... & Azzoli, C. G.

(2007). Pulmonary toxicity associated with erlotinib.

Chest, 132(3), 1042-1044. 5.

Scagliotti, G. V., Krzakowski, M., Szczesna, A., Strausz, J., Makhson, A., Reck, M., ... & Govindan, R.

(2012). Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non–small-cell lung cancer: a phase III trial.

Journal of clinical oncology, 30(17), 2070-2078.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026